bromodeoxyuridine has been researched along with Demyelinating Diseases in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.78) | 18.7374 |
| 1990's | 2 (5.56) | 18.2507 |
| 2000's | 16 (44.44) | 29.6817 |
| 2010's | 17 (47.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Correale, JD; Pasquini, JM; Pasquini, LA; Wies Mancini, VSB | 1 |
| Duncan, ID; Mayer, JA; Smith, CM | 1 |
| Chan, JR; Etxeberria, A; He, Y; Liu, S; Mei, F; Niu, J; Wang, H; Wang, L; Xiao, L | 1 |
| Chew, LJ; Fauveau, M; Gallo, V; Hong, E; Kerninon, C; Klopstein, A; Moll, NM; Nait Oumesmar, B; Naruse, M; Seilhean, D; Tepavcevic, V | 1 |
| Demeneix, BA; Javan, M; Lopez-Juarez, A; Mirnajafi-Zadeh, J; Morvan-Dubois, G; Mozafari, S; Pierre-Simons, J; Pourabdolhossein, F | 1 |
| Alliod, C; Fischer, K; Goebels, N; Harrer, MD; Pouly, S; Stoppini, L; von Büdingen, HC | 1 |
| Evans, GRD; Keirstead, HS; Kosins, AM; McConnell, MP; Mendoza, C; Scholz, T; Shepard, B | 1 |
| Badaracco, ME; Belforte, N; Bernabeu, R; Clausi, MG; Ortiz, EH; Pasquini, JM; Rosato-Siri, MV; Soto, EF | 1 |
| Aumann, TD; Cate, HS; Emery, B; Kemper, D; Kilpatrick, TJ; Merlo, D; Merson, TD; Perreau, VM; Robinson, J; Sabo, JK | 1 |
| Billings-Gagliardi, S; Haddady, S; Low, HP; Riskind, PN; Schwartz, WJ | 1 |
| Aguirre, A; Gallo, V; Jablonska, B; Kitabatake, Y; Ming, GL; Raymond, M; Sailor, KA; Song, H; Szabo, G | 1 |
| Anderegg, A; Awatramani, R; Feltri, ML; Menichella, D; Wrabetz, L; Yun, B | 1 |
| Chawla, R; Khan, HA; Sadaqat, M; Sajad, M; Umar, S; Zargan, J | 1 |
| Aumann, TD; Cate, HS; Kilpatrick, TJ; Merlo, D; Sabo, JK | 1 |
| Boyd, A; Jarjour, AA; Williams, A; Zhang, H | 1 |
| Devries, WH; Kuypers, NJ; Qiu, M; Whittemore, SR; Zhao, X; Zhu, Q | 1 |
| Chen, LP; Guo, L; Li, R; Li, ZF; Liu, J; Ping, M; Song, XJ; Xie, XH | 1 |
| Bernard, F; Chédotal, A; Dumas, L; Fouquet, S; Heitz-Marchaland, C; Lee, X; Mi, S; Moreau-Fauvarque, C; Shao, Z; Zagar, Y | 1 |
| Chen, T; Fang, Y; Guo, J; Liao, H; Song, S; Sun, J; Yan, J; Zhang, L | 1 |
| Nishiyama, A; Toyama, Y; Watanabe, M | 1 |
| Barthelaix-Pouplard, A; Fressinaud, C; Jean, I; Lavialle, C | 1 |
| Brismar, H; Brundin, L; Danilov, AI; Johansson, CB; Olsson, T | 1 |
| Dunning, MD; Franklin, RJ; Lakatos, A; Li, WW; Marchionni, M; Penderis, J; Woodruff, RH; Zhao, C | 1 |
| Blakemore, WF; Crang, AJ; Gilson, JM; Li, WW | 1 |
| Burshteyn, M; Casaccia-Bonnefil, P; Crockett, DP; Garcia, C; Muggironi, M | 1 |
| Franklin, RJ; Li, WW; Setzu, A; Zhao, C | 1 |
| Boehm, N; Ghandour, MS; Grucker, D; Jalabi, W | 1 |
| Alberta, JA; Guertin, AD; Kim, HA; Mak, KS; Zhang, DP | 1 |
| Bonilla, S; García-Verdugo, JM; Geijo, E; Martínez, S; Silva, A; Valdés, L | 1 |
| Adamo, AM; Escobar Cabrera, OE; Franco, PG; Paez, PM; Pasquini, JM; Soto, EF; Wolfson, M | 1 |
| Aguirre, A; Dupree, JL; Gallo, V; Mangin, JM | 1 |
| D'Antonio, M; Del Carro, U; Feltri, ML; Malaguti, M; Pennuto, M; Quattrini, A; Ron, D; Tinelli, E; Wrabetz, L | 1 |
| Johnson, JM; Tuohy, VK; Yu, M | 1 |
| Blakemore, WF; Keirstead, HS; Levine, JM | 1 |
| Bourque, JA; Peterson, AC; Tetzlaff, W; Vanderluit, JL | 1 |
| Latovitzki, N; Silberberg, DH | 1 |
36 other study(ies) available for bromodeoxyuridine and Demyelinating Diseases
| Article | Year |
|---|---|
Microglial modulation through colony-stimulating factor-1 receptor inhibition attenuates demyelination.
Topics: Amyloid beta-Peptides; Animals; Benzothiazoles; Brain; Bromodeoxyuridine; Cuprizone; Cytokines; Demyelinating Diseases; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Microglia; Microscopy, Electron, Transmission; Myelin Basic Protein; Nerve Tissue Proteins; Nitric Oxide Synthase Type II; Picolinic Acids; Receptors, Colony-Stimulating Factor; Time Factors | 2019 |
Autophagy promotes oligodendrocyte survival and function following dysmyelination in a long-lived myelin mutant.
Topics: Age Factors; Animals; Animals, Newborn; Autophagy; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Chloroquine; Cytoplasm; Demyelinating Diseases; Fasting; Female; Male; Microtubule-Associated Proteins; Mutation; Myelin Basic Protein; Myelin Proteolipid Protein; Myelin Sheath; Oligodendroglia; Peptides; Rats; Rats, Long-Evans; Rats, Mutant Strains; Spinal Cord; Up-Regulation | 2013 |
Stage-specific deletion of Olig2 conveys opposing functions on differentiation and maturation of oligodendrocytes.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Animals, Newborn; Arabidopsis Proteins; Autophagy-Related Proteins; Basic Helix-Loop-Helix Transcription Factors; Bromodeoxyuridine; Cell Differentiation; Cuprizone; Demyelinating Diseases; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Intramolecular Transferases; Male; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Monoamine Oxidase Inhibitors; Myelin Basic Protein; Myelin Proteolipid Protein; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Oligodendroglia; ran GTP-Binding Protein; Transfection | 2013 |
SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Topics: Aged; Animals; Antigens; Autophagy-Related Proteins; Basic Helix-Loop-Helix Transcription Factors; Brain; Bromodeoxyuridine; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Humans; Intracellular Signaling Peptides and Proteins; Leukocyte Common Antigens; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Middle Aged; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Myelin Basic Protein; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Proteoglycans; SOXF Transcription Factors; Time Factors; Up-Regulation | 2013 |
Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Bromodeoxyuridine; Cell Movement; Cell Proliferation; Demyelinating Diseases; Evoked Potentials, Visual; Gene Expression Regulation; GPI-Linked Proteins; Injections, Intraventricular; Lysophosphatidylcholines; Male; Mice; Mice, Inbred C57BL; Microinjections; Myelin Proteins; Myelin Sheath; Nerve Tissue Proteins; Nogo Receptor 1; Oligodendrocyte Transcription Factor 2; Optic Chiasm; Receptors, Cell Surface; Recovery of Function; RNA, Small Interfering; Stem Cells; Time Factors | 2014 |
Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Cerebral Cortex; Complement System Proteins; Demyelinating Diseases; Enzyme-Linked Immunosorbent Assay; Green Fluorescent Proteins; Immunoglobulins; Mice; Mice, Transgenic; Microscopy, Confocal; Myelin Basic Protein; Myelin Proteins; Myelin Proteolipid Protein; Myelin Sheath; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Oligodendroglia; Organ Culture Techniques; Specific Pathogen-Free Organisms; Time Factors | 2009 |
A novel model to measure the regenerative potential of the peripheral nervous system after experimental immunological demyelination.
Topics: Animals; Antimetabolites; Bromodeoxyuridine; Cell Movement; Demyelinating Diseases; Female; Myelin Sheath; Nerve Regeneration; Peripheral Nervous System; Rats; Rats, Sprague-Dawley; Regeneration; S100 Proteins; Schwann Cells; Sciatic Nerve | 2009 |
Oligodendrogenesis in iron-deficient rats: effect of apotransferrin.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Apoproteins; Basic Helix-Loop-Helix Transcription Factors; Body Weight; Brain; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Proliferation; Corpus Callosum; Demyelinating Diseases; Electroencephalography; Evoked Potentials, Visual; Female; Gene Expression Regulation, Developmental; Hematocrit; Iron Deficiencies; Myelin Basic Protein; Nerve Tissue Proteins; Neural Cell Adhesion Molecule L1; Oligodendroglia; Photic Stimulation; Pregnancy; Prenatal Exposure Delayed Effects; Proliferating Cell Nuclear Antigen; Rats; Sialic Acids; Transferrin | 2010 |
Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone-induced demyelination.
Topics: Animals; Antimetabolites; Astrocytes; Bone Morphogenetic Protein 4; Bone Morphogenetic Protein Receptors; Bone Morphogenetic Proteins; Brain; Bromodeoxyuridine; Carrier Proteins; Cell Count; Cell Differentiation; Cell Lineage; Cell Proliferation; Cerebral Ventricles; Cuprizone; Demyelinating Diseases; Injections, Intraventricular; Mice; Mice, Inbred C57BL; Microdissection; Monoamine Oxidase Inhibitors; Oligodendroglia; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2010 |
Pregnancy modulates precursor cell proliferation in a murine model of focal demyelination.
Topics: Animals; Antigens; Basic Helix-Loop-Helix Transcription Factors; Bromodeoxyuridine; Cell Lineage; Cell Proliferation; Central Nervous System; Corpus Callosum; Demyelinating Diseases; Disease Models, Animal; Female; Histones; Lysophosphatidylcholines; Mice; Nerve Fibers, Myelinated; Nerve Regeneration; Oligodendroglia; Pregnancy; Proteoglycans; Stem Cells | 2010 |
Chordin-induced lineage plasticity of adult SVZ neuroblasts after demyelination.
Topics: Adult Stem Cells; Animals; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Lineage; Cell Movement; Cerebral Ventricles; Corpus Callosum; Demyelinating Diseases; Doublecortin Domain Proteins; Doublecortin Protein; Gene Expression Regulation; Glutamate Decarboxylase; Glycoproteins; Green Fluorescent Proteins; Intercellular Signaling Peptides and Proteins; Lysophosphatidylcholines; Mice; Mice, Transgenic; Microtubule-Associated Proteins; Myelin Basic Protein; Nerve Tissue Proteins; Neurogenesis; Neuronal Plasticity; Neurons; Neuropeptides; Oligodendroglia | 2010 |
MicroRNA-deficient Schwann cells display congenital hypomyelination.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Cell Differentiation; Cyclin D1; DEAD-box RNA Helicases; Demyelinating Diseases; Disease Models, Animal; Early Growth Response Protein 2; Endoribonucleases; Female; Gene Expression Profiling; Gene Expression Regulation, Developmental; Indoles; Male; Mice; Mice, Knockout; MicroRNAs; Microscopy, Electron, Transmission; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins c-jun; Ribonuclease III; Schwann Cells; Sciatic Nerve; SOXB1 Transcription Factors | 2010 |
Cytokinetics of adult rat SVZ after EAE.
Topics: Animals; Apoptosis; Blood-Brain Barrier; Bromodeoxyuridine; Cell Cycle; Demyelinating Diseases; DNA Replication; Encephalomyelitis, Autoimmune, Experimental; Female; In Situ Nick-End Labeling; Lateral Ventricles; Neurogenesis; Neurons; Rats; Rats, Wistar | 2011 |
Remyelination is altered by bone morphogenic protein signaling in demyelinated lesions.
Topics: Animals; Antimetabolites; Astrocytes; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Bromodeoxyuridine; Carrier Proteins; Cell Count; Chelating Agents; Corpus Callosum; Cuprizone; Demyelinating Diseases; Female; Mice; Mice, Inbred C57BL; Microscopy, Electron; Myelin Sheath; Neuroglia; Oligodendroglia; Signal Transduction; Stem Cells | 2011 |
Central nervous system remyelination in culture--a tool for multiple sclerosis research.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Analysis of Variance; Animals; Animals, Newborn; Antigens; Bromodeoxyuridine; Cell Proliferation; Central Nervous System; Demyelinating Diseases; Green Fluorescent Proteins; Lysophosphatidylcholines; Mice; Mice, Transgenic; Models, Biological; Myelin Basic Protein; Myelin Sheath; Neurofilament Proteins; Oligodendroglia; Organ Culture Techniques; Proteoglycans; RNA, Messenger; Stem Cells | 2011 |
Dorsally-derived oligodendrocytes in the spinal cord contribute to axonal myelination during development and remyelination following focal demyelination.
Topics: Animals; Antimetabolites; Axons; Bromodeoxyuridine; Cell Differentiation; Data Interpretation, Statistical; Demyelinating Diseases; Fluorescent Antibody Technique; Green Fluorescent Proteins; Immunohistochemistry; Lac Operon; Mice; Mice, Transgenic; Microscopy, Confocal; Microscopy, Electron; Myelin Sheath; Neural Stem Cells; Oligodendroglia; Paired Box Transcription Factors; PAX3 Transcription Factor; Spinal Cord; Spinal Cord Injuries | 2011 |
Regulation of Olig2 during astroglial differentiation in the subventricular zone of a cuprizone-induced demyelination mouse model.
Topics: Adult Stem Cells; Amidines; Animals; Animals, Newborn; Astrocytes; Basic Helix-Loop-Helix Transcription Factors; Bone Morphogenetic Protein 2; Bone Morphogenetic Protein 4; Bromodeoxyuridine; Cell Differentiation; Cells, Cultured; Cerebral Ventricles; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Gangliosides; Gene Expression Regulation; Inhibitor of Differentiation Protein 2; Inhibitor of Differentiation Proteins; Mice; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Rats, Sprague-Dawley | 2012 |
Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination.
Topics: Age Factors; Animals; Animals, Newborn; Antigens, Differentiation; Basic Helix-Loop-Helix Transcription Factors; Brain; Bromodeoxyuridine; Cell Differentiation; Cells, Cultured; Coculture Techniques; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Embryo, Mammalian; Female; Ganglia, Spinal; Gene Expression Regulation, Developmental; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monoamine Oxidase Inhibitors; Mutation; Myelin Basic Protein; Myelin Proteolipid Protein; Myelin Sheath; Nerve Tissue Proteins; Neurons; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Pregnancy; Ranvier's Nodes; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cell Surface; RNA, Messenger; Semaphorins; Stem Cells; Time Factors; Transcription Factors | 2012 |
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination.
Topics: Animals; Antimetabolites; Benzoxazines; Blotting, Western; Brain Ischemia; Bromodeoxyuridine; Cannabinoid Receptor Antagonists; Cell Differentiation; Cell Survival; Demyelinating Diseases; Immunohistochemistry; Indicators and Reagents; Male; MAP Kinase Signaling System; Microscopy, Electron; Morpholines; Myelin Basic Protein; Myelin Sheath; Naphthalenes; Oligodendroglia; Phosphorylation; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Stroke | 2013 |
Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion.
Topics: Age Factors; Animals; Antigens; Antimetabolites; Bromodeoxyuridine; Cell Differentiation; Cell Division; Demyelinating Diseases; Female; Lysophosphatidylcholines; Myelin Sheath; Nerve Regeneration; Oligodendroglia; Proteoglycans; Rats; Rats, Inbred Strains; Spinal Cord; Stem Cells | 2002 |
Neurotrophin-3 specifically increases mature oligodendrocyte population and enhances remyelination after chemical demyelination of adult rat CNS.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Bromodeoxyuridine; Central Nervous System Diseases; Corpus Callosum; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Immunohistochemistry; Lysophosphatidylcholines; Male; Myelin Basic Protein; Nerve Regeneration; Neurotrophin 3; Oligodendroglia; Rats; Rats, Wistar; Stem Cells; Time Factors | 2003 |
Neural stem cells: a potential source for remyelination in neuroinflammatory disease.
Topics: Animals; Bromodeoxyuridine; Carbocyanines; Cell Count; Demyelinating Diseases; Disease Models, Animal; Ectodysplasins; Encephalomyelitis, Autoimmune, Experimental; Ependyma; Female; Fluorescent Dyes; Freund's Adjuvant; Glial Fibrillary Acidic Protein; Indoles; Macrophages; Membrane Proteins; Microscopy, Confocal; Myelin Proteins; Myelin Sheath; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; O Antigens; Rats; Rats, Inbred Strains; Spinal Cord; Stem Cells; Time Factors | 2003 |
Increasing local levels of neuregulin (glial growth factor-2) by direct infusion into areas of demyelination does not alter remyelination in the rat CNS.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; Cells, Cultured; Central Nervous System; Demyelinating Diseases; Dose-Response Relationship, Drug; Drug Administration Routes; Enzyme Inhibitors; Ethidium; Female; Immunohistochemistry; In Vitro Techniques; Indoles; Myelin Sheath; Nerve Tissue Proteins; Neuregulin-1; Oligodendroglia; Rats; Rats, Sprague-Dawley; Receptor, ErbB-2; Receptor, ErbB-3; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Schwann Cells; Time Factors | 2003 |
The remyelinating potential and in vitro differentiation of MOG-expressing oligodendrocyte precursors isolated from the adult rat CNS.
Topics: Animals; Axons; Benzimidazoles; Blotting, Western; Bone Morphogenetic Proteins; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Division; Cell Survival; Cells, Cultured; Central Nervous System; Cyclophilins; Demyelinating Diseases; Epidermal Growth Factor; Ethidium; Female; Flow Cytometry; Glial Fibrillary Acidic Protein; Immunohistochemistry; In Vitro Techniques; Intermediate Filament Proteins; Microscopy, Electron, Scanning Transmission; Myelin Proteins; Myelin Sheath; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Nerve Regeneration; Nerve Tissue Proteins; Nestin; Octamer Transcription Factor-6; Oligodendroglia; Rats; Receptors, Platelet-Derived Growth Factor; Stem Cells; Time Factors; Transcription Factors; Transplants | 2004 |
Number of oligodendrocyte progenitors recruited to the lesioned spinal cord is modulated by the levels of the cell cycle regulatory protein p27Kip-1.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Demyelinating Diseases; Female; Gene Expression Regulation; Lysophosphatidylcholines; Male; Mice; Mice, Knockout; Myelin Basic Protein; Nerve Regeneration; Oligodendroglia; S Phase; Spinal Cord Diseases; Stem Cells; Tumor Suppressor Proteins | 2005 |
Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bromodeoxyuridine; CD11b Antigen; Cell Count; Cells, Cultured; Cerebellum; Demyelinating Diseases; Disease Models, Animal; Dose-Response Relationship, Drug; Ethidium; Female; Fluorescent Antibody Technique; Genes, MHC Class II; In Situ Hybridization; Microglia; Minocycline; Oligodendroglia; Rats; Staining and Labeling; Stem Cells; Time Factors | 2005 |
Recovery of myelin after induction of oligodendrocyte cell death in postnatal brain.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Antiviral Agents; Brain; Bromodeoxyuridine; Cell Death; Demyelinating Diseases; Disease Models, Animal; Ganciclovir; Gene Expression Regulation, Developmental; Herpesvirus 1, Human; Immunohistochemistry; In Situ Hybridization; Male; Mice; Mice, Transgenic; Microscopy, Electron, Transmission; Myelin Basic Protein; Myelin Sheath; Oligodendroglia; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thymidine Kinase | 2005 |
Microanatomy of axon/glial signaling during Wallerian degeneration.
Topics: Analysis of Variance; Animals; Axotomy; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Coculture Techniques; Demyelinating Diseases; Disease Models, Animal; Embryo, Mammalian; Female; Fluorescent Antibody Technique; Ganglia, Spinal; Gene Expression; Glycoproteins; Immunoprecipitation; Mitogen-Activated Protein Kinase Kinases; Myelin Basic Protein; Myelin Sheath; Neuregulins; Neuroglia; Neurons; Platelet-Derived Growth Factor; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, ErbB-2; Schwann Cells; Sciatic Neuropathy; Signal Transduction; Sodium Channels; Time Factors; Wallerian Degeneration | 2005 |
Functional neural stem cells derived from adult bone marrow.
Topics: Animals; Animals, Newborn; Bone Marrow Cells; Brain; Bromodeoxyuridine; Cell Differentiation; Demyelinating Diseases; DNA; Electrophysiology; Green Fluorescent Proteins; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Electron; Neurons; Stem Cell Transplantation; Stem Cells | 2005 |
Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antigens; Apoproteins; Brain; Bromodeoxyuridine; CD11b Antigen; Cell Count; Cuprizone; Cytoskeletal Proteins; Demyelinating Diseases; Drug Interactions; Galactolipids; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indoles; Myelin Basic Protein; Myelin Sheath; Proteoglycans; Rats; Rats, Wistar; Recovery of Function; Regeneration; Time Factors; Transferrin | 2006 |
A functional role for EGFR signaling in myelination and remyelination.
Topics: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; Adult Stem Cells; Animals; Animals, Newborn; Bromodeoxyuridine; Cell Proliferation; Demyelinating Diseases; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Gene Expression Regulation; Green Fluorescent Proteins; Humans; Lysophosphatidylcholines; Mice; Mice, Mutant Strains; Mice, Transgenic; Microscopy, Electron, Transmission; Myelin Sheath; Nerve Regeneration; Nerve Tissue Proteins; Oligodendroglia; Phosphoric Diester Hydrolases; Signal Transduction | 2007 |
Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice.
Topics: Age Factors; Animals; Animals, Newborn; Bromodeoxyuridine; Charcot-Marie-Tooth Disease; CHO Cells; Cricetinae; Cricetulus; Demyelinating Diseases; Disease Models, Animal; Endoplasmic Reticulum; Gene Expression Regulation; In Situ Nick-End Labeling; Mice; Mice, Transgenic; Motor Activity; Mutation; Myelin P0 Protein; Nerve Fibers, Myelinated; Signal Transduction; Transcription Factor CHOP; Transfection | 2008 |
Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
Topics: Adoptive Transfer; Animals; Antigen Presentation; Antimetabolites; Autoantigens; Bisbenzimidazole; Bromodeoxyuridine; Central Nervous System Diseases; Cytokines; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Epitopes; Female; Fluorescent Dyes; Immunization; Mice; Mice, Inbred Strains; Myelin Basic Protein; Myelin Proteins; Myelin Proteolipid Protein; Peptide Fragments; Photochemistry; Spleen; T-Lymphocytes, Helper-Inducer | 1996 |
Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Bromodeoxyuridine; Cell Count; Demyelinating Diseases; Female; Immunohistochemistry; Microscopy, Electron; Oligodendroglia; Radiography; Rats; Rats, Sprague-Dawley; Spinal Cord; Stem Cells; Tolonium Chloride | 1998 |
Model for focal demyelination of the spinal dorsal columns of transgenic MBP-LacZ mice by phototargeted ablation of oligodendrocytes.
Topics: Animals; beta-Galactosidase; Bromodeoxyuridine; Cell Count; Demyelinating Diseases; Disease Models, Animal; Fluoresceins; Galactosides; Light; Mice; Mice, Transgenic; Myelin Basic Protein; Oligodendroglia; Promoter Regions, Genetic; Spinal Cord | 2000 |
Ceramide glycosyltransferases in cultured rat cerebellum: changes with age, with demyelination, and with inhibition of myelination by 5-bromo-2'-deoxyuridine or experimental allergic encephalomyelitis serum.
Topics: Age Factors; Animals; Bromodeoxyuridine; Cells, Cultured; Ceramides; Cerebellum; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Glucosyltransferases; Hexosyltransferases; In Vitro Techniques; Myelin Sheath; Rats; Tritium; Uridine Diphosphate Galactose; Uridine Diphosphate Glucose | 1975 |